Anna Hirsch

Professor Dr. Anna Hirsch is a faculty member at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), affiliated with the Faculty of Natural Sciences and Technology and the Department of Pharmaceutical Science. She holds the Chair of Medicinal Chemistry and leads an active research group focused on the development of novel anti-infective agents.

Her research interests lie at the intersection of medicinal chemistry and infectious disease, with a strong emphasis on structure-based rational drug design. The Hirsch group targets biologically relevant but understudied proteins such as enzymes, transporters, and regulators from bacterial and parasitic pathogens. They employ a multidisciplinary approach combining biophysical interaction studies, in vitro assays, and cell-based evaluation systems to identify and optimize lead compounds. A key aspect of their work involves multiparameter optimization to enhance drug efficacy, selectivity, and pharmacokinetic properties.

The research output reflects a consistent focus on anti-infective drug discovery, particularly against challenging microbial and parasitic targets. Although specific publications are not listed, the described methodology and objectives suggest strong contributions to the fields of medicinal chemistry and pharmaceutical sciences.

• No scientific awards were mentioned in the provided text.

As principal investigator, Prof. Hirsch advises and mentors researchers within her group, though specific names of students or trainees are not provided. There is no mention of external grants, but her leadership of a research group at HIPS implies involvement in funded research projects.

The Hirsch research group ("Hirsch-Gruppe") operates within the Wirkstoffdesign und Optimierung (Drug Design and Optimization) department at HIPS, located on the Saarbrücken University campus. The team utilizes advanced drug discovery platforms and maintains a strong focus on translating structural insights into therapeutic candidates.